FDA Releases Draft Guidance on Heparin Quality for Drug and Medical Device Manufacturers

Summary

The Food and Drug Administration (FDA) has made available a draft guidance document to inform manufacturers of active pharmaceutical ingredients (APIs), pharmaceutical and medical device manufacturers of finished products, and others about the potential risk of crude heparin contamination in their products.